MetLife Investment Management’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-36,788
| Closed | -$484K | – | 2817 |
|
|
2024
Q4 | $484K | Buy |
36,788
+3,925
| +12% | +$51.7K | ﹤0.01% | 1819 |
|
|
2024
Q3 | $368K | Hold |
32,863
| – | – | ﹤0.01% | 1953 |
|
|
2024
Q2 | $353K | Buy |
32,863
+3,049
| +10% | +$32.8K | ﹤0.01% | 1919 |
|
|
2024
Q1 | $444K | Hold |
29,814
| – | – | ﹤0.01% | 1740 |
|
|
2023
Q4 | $540K | Hold |
29,814
| – | – | ﹤0.01% | 1641 |
|
|
2023
Q3 | $517K | Hold |
29,814
| – | – | ﹤0.01% | 1613 |
|
|
2023
Q2 | $540K | Buy |
+29,814
| New | +$540K | ﹤0.01% | 1647 |
|
|
2022
Q1 | – | Sell |
-9,508
| Closed | -$128K | – | 2760 |
|
|
2021
Q4 | $128K | Hold |
9,508
| – | – | ﹤0.01% | 2311 |
|
|
2021
Q3 | $160K | Hold |
9,508
| – | – | ﹤0.01% | 2218 |
|
|
2021
Q2 | $277K | Hold |
9,508
| – | – | ﹤0.01% | 1941 |
|
|
2021
Q1 | $374K | Buy |
9,508
+4,633
| +95% | +$182K | ﹤0.01% | 1690 |
|
|
2020
Q4 | $111K | Hold |
4,875
| – | – | ﹤0.01% | 2218 |
|
|
2020
Q3 | $110K | Buy |
+4,875
| New | +$110K | ﹤0.01% | 2169 |
|